初诊Graves眼病患者生活质量及其影响因素

Evaluation of quality of life in patients with Graves orbitopathy and its influencing factors

目的评估Graves眼病(Graves orbitopathy,GO)患者的生活质量,分析与生活质量相关的影响因素,为临床病情评估提供依据。方法选取2016年3月—2018年10月南方医科大学第三附属医院内分泌科就诊的145例初诊GO患者,收集所有患者的人口学资料、眼部病情评估情况及相关临床检验指标,以欧洲Graves眼病协作组(EUGOGO)严重程度分级为依据,将患者分为轻度及中重度两组。使用GO患者的生活质量(the Graves orbitopathy quality of life,GO-QOL)量表(包括视功能量表和社会功能量表,满分为100分,得分越高,生活质量越好)评估患者的生活质量,比较两组量表得分的差异,接着分析与GO患者生活质量相关的影响因素,最后评估GO-QOL量表的衰减效应。结果(1)145例GO患者的GO-QOL视功能量表得分(70.91±27.83)分,社会功能量表得分(61.29±26.37)分。中重度GO患者的GO-QOL视功能量表、社会功能量表得分均低于轻度GO患者[(62.71±28.77)分比(85.58±18.77)分,(57.52±26.49)分比(68.02±24.99)分,P值均<0.05]。(2)中重度GO患者视功能量表得分与患者的年龄(P=0.002)、疾病活动度(P=0.011)以及复视情况(P=0.001)存在相关性(R2=0.373);社会功能量表得分与患者的性别(P=0.05)及促甲状腺激素水平(P=0.001)具有相关性(R2=0.231)。(3)GO-QOL两个子量表在中重度GO患者中未见显著的天花板效应及地板效应。结论GO患者的生活质量下降,与病情严重程度相关,年龄、性别、复视情况、病情活动度和促甲状腺激素水平等是GO患者生活质量的影响因素。GO患者的生活质量相关问题应引起关注。

Objective To evaluate life quality of Graves orbitopathy (GO) patients using Graves orbitopathy quality-of-life questionnaire (GO-QOL) and explore the influence factors of the quality of life of GO patients. Methods This was a cross-sectional study conducted at The Third Affiliated Hospital of Southern Medical University including 145 newly diagnosed GO patients. All the patient answered the GO-QOL and underwent ophthalmic and endocrine assessments. The main outcome measures were the scores on GO-QOL 2 subscales: visual functioning and appearance. Based on the classification in the guideline of European Group on Graves Orbitopathy (EUGOGO), the patients were divided into two groups: mild and moderate to severe groups. Then the scales between these two groups were compared and influencing factors were analyzed. Finally, the floor and ceiling effects were assessed. Results The GO-QOL scores for the subscales of visual functioning and appearance were 70.91±27.83 and 61.29±26.37 respectively in 145 GO patients. Visual functioning and appearance were lower in moderate to severe group (62.71±28.77 and 57.52±26.49, respectively) than in mild group (85.58±18.77 and 68.02±24.99, respectively).The GO-QOL scores for the visual functioning subscale were significantly correlated with age (P=0.002), clinical active score (P=0.011) and the degree of diplopia (P=0.00, R2=0.373). The GO-QOL scores for the appearance were significantly correlated with sex (P=0.05) and thyroid-stimulating hormone levels (P=0.001, R2=0.231). No significant ceiling or floor effects were observed for either subscale of the GO-QOL. Conclusions With the aggravation of the disease, the quality of life of GO patients is getting worse and worse. The main influencing factors of the quality of life of GO patients include age, gender, diplopia, clinical active score and thyroid-stimulating hormone levels. Close attention needs to be paid to the quality of life of GO patients.